Legis Daily

Triple-Negative Breast Cancer Research and Education Act of 2025

USA119th CongressHR-1806| House 
| Updated: 3/3/2025
Joseph D. Morelle

Joseph D. Morelle

Democratic Representative

New York

Cosponsors (12)
Dwight Evans (Democratic)Steve Cohen (Democratic)Paul Tonko (Democratic)Shri Thanedar (Democratic)Henry C. "Hank" Johnson (Democratic)Sheila Cherfilus-McCormick (Democratic)Don Bacon (Republican)Kathy Castor (Democratic)Eleanor Holmes Norton (Democratic)Brian K. Fitzpatrick (Republican)Josh Gottheimer (Democratic)Kweisi Mfume (Democratic)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill aims to significantly enhance efforts against triple-negative breast cancer (TNBC), an aggressive form of the disease disproportionately affecting minority women. It directs the National Institutes of Health (NIH) to expand, intensify, and coordinate research programs specifically focused on TNBC, utilizing various relevant institutes and offices within the NIH. This research will seek to address gaps in understanding TNBC's prevalence, costs, and prevention methods, especially among minority populations. Furthermore, the legislation mandates the Secretary of Health and Human Services , through the Centers for Disease Control and Prevention, to create and distribute public information about TNBC, covering its incidence, prevalence, the heightened risk for minority women, and available treatment options. Concurrently, the Health Resources and Services Administration will be responsible for informing healthcare providers about current TNBC information, including the elevated risk among minority women and treatment approaches, ensuring they remain well-informed. Appropriations are authorized for these research and education initiatives for fiscal years 2026 through 2031.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-5939
Triple-Negative Breast Cancer Research and Education Act of 2019

Bill from Previous Congress

HR 117-113
Triple-Negative Breast Cancer Research and Education Act of 2021

Bill from Previous Congress

HR 118-235
Triple-Negative Breast Cancer Research and Education Act of 2023
Mar 3, 2025
Introduced in House
Mar 3, 2025
Referred to the House Committee on Energy and Commerce.
  • Bill from Previous Congress

    HR 116-5939
    Triple-Negative Breast Cancer Research and Education Act of 2019


  • Bill from Previous Congress

    HR 117-113
    Triple-Negative Breast Cancer Research and Education Act of 2021


  • Bill from Previous Congress

    HR 118-235
    Triple-Negative Breast Cancer Research and Education Act of 2023


  • March 3, 2025
    Introduced in House


  • March 3, 2025
    Referred to the House Committee on Energy and Commerce.

Health

Triple-Negative Breast Cancer Research and Education Act of 2025

USA119th CongressHR-1806| House 
| Updated: 3/3/2025
This bill aims to significantly enhance efforts against triple-negative breast cancer (TNBC), an aggressive form of the disease disproportionately affecting minority women. It directs the National Institutes of Health (NIH) to expand, intensify, and coordinate research programs specifically focused on TNBC, utilizing various relevant institutes and offices within the NIH. This research will seek to address gaps in understanding TNBC's prevalence, costs, and prevention methods, especially among minority populations. Furthermore, the legislation mandates the Secretary of Health and Human Services , through the Centers for Disease Control and Prevention, to create and distribute public information about TNBC, covering its incidence, prevalence, the heightened risk for minority women, and available treatment options. Concurrently, the Health Resources and Services Administration will be responsible for informing healthcare providers about current TNBC information, including the elevated risk among minority women and treatment approaches, ensuring they remain well-informed. Appropriations are authorized for these research and education initiatives for fiscal years 2026 through 2031.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-5939
Triple-Negative Breast Cancer Research and Education Act of 2019

Bill from Previous Congress

HR 117-113
Triple-Negative Breast Cancer Research and Education Act of 2021

Bill from Previous Congress

HR 118-235
Triple-Negative Breast Cancer Research and Education Act of 2023
Mar 3, 2025
Introduced in House
Mar 3, 2025
Referred to the House Committee on Energy and Commerce.
  • Bill from Previous Congress

    HR 116-5939
    Triple-Negative Breast Cancer Research and Education Act of 2019


  • Bill from Previous Congress

    HR 117-113
    Triple-Negative Breast Cancer Research and Education Act of 2021


  • Bill from Previous Congress

    HR 118-235
    Triple-Negative Breast Cancer Research and Education Act of 2023


  • March 3, 2025
    Introduced in House


  • March 3, 2025
    Referred to the House Committee on Energy and Commerce.
Joseph D. Morelle

Joseph D. Morelle

Democratic Representative

New York

Cosponsors (12)
Dwight Evans (Democratic)Steve Cohen (Democratic)Paul Tonko (Democratic)Shri Thanedar (Democratic)Henry C. "Hank" Johnson (Democratic)Sheila Cherfilus-McCormick (Democratic)Don Bacon (Republican)Kathy Castor (Democratic)Eleanor Holmes Norton (Democratic)Brian K. Fitzpatrick (Republican)Josh Gottheimer (Democratic)Kweisi Mfume (Democratic)

Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted